245 related articles for article (PubMed ID: 22844497)
21. YopJ-induced caspase-1 activation in Yersinia-infected macrophages: independent of apoptosis, linked to necrosis, dispensable for innate host defense.
Zheng Y; Lilo S; Mena P; Bliska JB
PLoS One; 2012; 7(4):e36019. PubMed ID: 22563435
[TBL] [Abstract][Full Text] [Related]
22. The small RNA PrrH aggravates
Shi Q; Zeng S; Yu R; Li M; Shen C; Zhang X; Zhao C; Zeng J; Huang B; Pu J; Chen C
Microbiol Spectr; 2024 Mar; 12(3):e0062623. PubMed ID: 38289930
[No Abstract] [Full Text] [Related]
23. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection.
Song Z; Wu H; Ciofu O; Kong KF; Høiby N; Rygaard J; Kharazmi A; Mathee K
J Med Microbiol; 2003 Sep; 52(Pt 9):731-740. PubMed ID: 12909647
[TBL] [Abstract][Full Text] [Related]
24. Membrane and chaperone recognition by the major translocator protein PopB of the type III secretion system of Pseudomonas aeruginosa.
Discola KF; Förster A; Boulay F; Simorre JP; Attree I; Dessen A; Job V
J Biol Chem; 2014 Feb; 289(6):3591-601. PubMed ID: 24297169
[TBL] [Abstract][Full Text] [Related]
25. Requirement of the Pseudomonas aeruginosa CbrA sensor kinase for full virulence in a murine acute lung infection model.
Yeung AT; Janot L; Pena OM; Neidig A; Kukavica-Ibrulj I; Hilchie A; Levesque RC; Overhage J; Hancock RE
Infect Immun; 2014 Mar; 82(3):1256-67. PubMed ID: 24379284
[TBL] [Abstract][Full Text] [Related]
26. [Molecular determinants in regulating Pseudomonas aeruginosa type III secretion system--a review].
Luo Q; Jin S
Wei Sheng Wu Xue Bao; 2008 Oct; 48(10):1413-7. PubMed ID: 19160828
[TBL] [Abstract][Full Text] [Related]
27. Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection.
Jyot J; Balloy V; Jouvion G; Verma A; Touqui L; Huerre M; Chignard M; Ramphal R
J Infect Dis; 2011 May; 203(10):1369-77. PubMed ID: 21502078
[TBL] [Abstract][Full Text] [Related]
28. Correlation between cytotoxicity induced by Pseudomonas aeruginosa clinical isolates from acute infections and IL-1β secretion in a model of human THP-1 monocytes.
Anantharajah A; Buyck JM; Faure E; Glupczynski Y; Rodriguez-Villalobos H; De Vos D; Pirnay JP; Bilocq F; Guery B; Tulkens PM; Mingeot-Leclercq MP; Van Bambeke F
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26203053
[TBL] [Abstract][Full Text] [Related]
29. The Pseudomonas aeruginosa Type III Secretion System Exoenzyme Effector ExoU Induces Mitochondrial Damage in a Murine Bone Marrow-Derived Macrophage Infection Model.
Hardy KS; Tuckey AN; Housley NA; Andrews J; Patel M; Al-Mehdi AB; Barrington RA; Cassel SL; Sutterwala FS; Audia JP
Infect Immun; 2022 Mar; 90(3):e0047021. PubMed ID: 35130452
[TBL] [Abstract][Full Text] [Related]
30. Pore-forming activity of the Pseudomonas aeruginosa type III secretion system translocon alters the host epigenome.
Dortet L; Lombardi C; Cretin F; Dessen A; Filloux A
Nat Microbiol; 2018 Mar; 3(3):378-386. PubMed ID: 29403015
[TBL] [Abstract][Full Text] [Related]
31. Injection of Pseudomonas aeruginosa Exo toxins into host cells can be modulated by host factors at the level of translocon assembly and/or activity.
Verove J; Bernarde C; Bohn YS; Boulay F; Rabiet MJ; Attree I; Cretin F
PLoS One; 2012; 7(1):e30488. PubMed ID: 22299042
[TBL] [Abstract][Full Text] [Related]
32. Affecting Pseudomonas aeruginosa phenotypic plasticity by quorum sensing dysregulation hampers pathogenicity in murine chronic lung infection.
Bondí R; Messina M; De Fino I; Bragonzi A; Rampioni G; Leoni L
PLoS One; 2014; 9(11):e112105. PubMed ID: 25420086
[TBL] [Abstract][Full Text] [Related]
33. PopB-PcrV Interactions Are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon.
Kundracik E; Trichka J; Díaz Aponte J; Roistacher A; Rietsch A
mBio; 2022 Oct; 13(5):e0238122. PubMed ID: 36154276
[TBL] [Abstract][Full Text] [Related]
34. Multiple Pseudomonas species secrete exolysin-like toxins and provoke Caspase-1-dependent macrophage death.
Basso P; Wallet P; Elsen S; Soleilhac E; Henry T; Faudry E; Attrée I
Environ Microbiol; 2017 Oct; 19(10):4045-4064. PubMed ID: 28654176
[TBL] [Abstract][Full Text] [Related]
35. Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response.
Phuong MS; Hernandez RE; Wolter DJ; Hoffman LR; Sad S
Cell Death Dis; 2021 Mar; 12(3):241. PubMed ID: 33664232
[TBL] [Abstract][Full Text] [Related]
36. CrkII/Abl phosphorylation cascade is critical for NLRC4 inflammasome activity and is blocked by Pseudomonas aeruginosa ExoT.
Mohamed MF; Gupta K; Goldufsky JW; Roy R; Callaghan LT; Wetzel DM; Kuzel TM; Reiser J; Shafikhani SH
Nat Commun; 2022 Mar; 13(1):1295. PubMed ID: 35277504
[TBL] [Abstract][Full Text] [Related]
37. A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages.
Zheng Y; Lilo S; Brodsky IE; Zhang Y; Medzhitov R; Marcu KB; Bliska JB
PLoS Pathog; 2011 Apr; 7(4):e1002026. PubMed ID: 21533069
[TBL] [Abstract][Full Text] [Related]
38. AIM2 inflammasome is dispensable for the host defense against Pseudomonas aeruginosa infection.
Pang Z; Sun G; Junkins RD; Lin TJ
Cell Mol Biol (Noisy-le-grand); 2015 Jun; 61(3):63-70. PubMed ID: 26107502
[TBL] [Abstract][Full Text] [Related]
39. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa.
Skerrett SJ; Wilson CB; Liggitt HD; Hajjar AM
Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L312-22. PubMed ID: 16936244
[TBL] [Abstract][Full Text] [Related]
40. Secretion of Flagellar Proteins by the Pseudomonas aeruginosa Type III Secretion-Injectisome System.
Ince D; Sutterwala FS; Yahr TL
J Bacteriol; 2015 Jun; 197(12):2003-11. PubMed ID: 25845843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]